Patients taking GLP-1 drugs lose weight faster, but they may experience side effects, such as nausea, vomiting, diarrhea, indigestion, fatigue, dizziness, and hypoglycemia, along with other potential adverse events
Because the original research concerned the gut, PLIVA tested it in the bowel disease ulcerative colitis, given as an enema, in a randomized, placebo-controlled study [11]
What form does it ship in
Less sensitivity to foods that previously caused issues
This may also be because catecholamines might represent a common pathway in the evolution of myocardial changes in humans who develop myocardial lesions without the narrowing or obstruction of coronary arteries [24]